Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
शेयरों में रैंक #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
शेयर मूल्य
$0.25974701
अंतिम समन्वयन: 2025-01-06
मार्केट कैप
$2.04M
बदलाव (1 दिन)
0.74%
बदलाव (1 वर्ष)
0.00%
देश
FR
व्यापार Acticor Biotech SAS (ALACT)

श्रेणी

Healthcare
Acticor Biotech SAS (ALACT) के लिए P/B अनुपात
September 2026 को P/B अनुपात TTM: -0.57
Acticor Biotech SAS की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) -0.57 है। 2022 के अंत में, कंपनी का P/B अनुपात -33.19 था।
Acticor Biotech SAS के लिए 2010 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
2026 (TTM) -0.57 -91.38%
2023 -6.59 -80.15%
2022 -33.19 -1,126.36%
2021 3.23 -87.62%
2020 26.12 538.96%
2019 4.09 17.85%
2018 3.47 -160.01%
2017 -5.78 -511.84%
2016 1.40 2.83%
2015 1.37 7.92%
2014 1.26 5.23%
2013 1.20 -8.34%
2012 1.31 -12.44%
2011 1.50 -91.22%
2010 17.05 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5144 -1,247.10%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3983 -1,402.75%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9974 -803.89%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.5918 -1,612.91%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH